伴侣动物保健市场规模、份额和成长分析（按产品类型、动物种类、最终用户、通路和地区划分）－2026-2033年产业预测

预计到 2024 年，伴侣动物保健市场规模将达到 273.8 亿美元，到 2025 年将达到 296.8 亿美元，到 2033 年将达到 565.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.4%。

远距办公的普及显着推动了宠物饲养量的成长，因为人们寻求陪伴来对抗社交隔离带来的忧郁和焦虑。调查显示，宠物在家庭生活中占据重要地位，相当多的家庭都饲养宠物。癌症发生率的上升，尤其是在犬类中，预计将进一步推动宠物医疗保健市场的成长，凸显了对更完善的兽医服务和治疗方法的需求。同时，宠物饲养量的成长也促使企业采取策略性倡议，以扩大其在动物医疗保健领域的市场占有率。这些倡议，包括收购，有望改善人们获得高品质兽医服务的途径，并促进该行业的可持续发展。

伴侣动物保健市场驱动因素

全球宠物饲养量的持续成长是伴侣动物医疗保健市场发展的关键驱动力。随着越来越多的人选择将宠物作为伴侣融入生活，对包括兽医护理、疫苗接种和健康维护产品在内的医疗保健服务的需求也随之上升。宠物饲养量的激增归因于多种因素，包括城市生活、生活方式的改变以及人们对宠物饲养益处的认识不断提高。因此，对伴侣动物专业医疗保健解决方案的需求持续增长，这反映了人类与动物关係的变化以及人们对宠物健康的日益重视。

伴侣动物保健市场限制因素

伴侣动物医疗保健市场面临的主要限制因素之一是兽医服务费用高昂。虽然先进的治疗方法可以显着改善动物的健康状况，但其高昂的费用给许多饲主带来了沉重的经济负担。这种经济障碍会限制宠物主人获得必要的医疗保健服务，尤其对于中低收入饲主，最终可能导致宠物无法获得全面的健康解决方案。因此，许多饲主难以负担必要的治疗费用，这可能导致医疗资源利用不足，并可能降低动物的整体福祉。

伴侣动物医疗保健市场趋势

伴侣动物医疗保健市场正经历着一个显着的趋势：宠物保险的普及率不断提高。这主要归因于饲主对宠物保险经济效益的意识提升不断增强以及兽医护理成本的不断上涨。随着饲主希望在不造成过重经济负担的情况下改善宠物的健康状况，对全面保险的需求日益增长。这种转变不仅显示人们对负责任的宠物饲养意识不断增强，也预示着一种文化转变，即人们更加重视伴侣动物的健康和福祉，从而塑造宠物医疗保健服务的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 专利分析
• 案例研究

全球伴侣动物保健市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 製药
  • 抗生素
  • 抗发炎药
  • 驱虫药
  • 疼痛管理
  • 其他的
• 疫苗
  • 减毒活病毒疫苗
  • 灭活疫苗
  • 重组疫苗
  • 其他的
• 诊断试剂
  • 免疫诊断测试
  • 分子诊断
  • 诊断影像检查
  • 临床化学
  • 其他的
• 饲料添加剂
  • 营养饲料添加剂
  • 药用饲料添加剂

全球伴侣动物保健市场规模（按动物类型划分）及复合年增长率（2026-2033 年）

• 狗
• 猫
• 马
• 其他的

全球伴侣动物保健市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 兽医医院和诊所
• 诊断检查室
• 研究所
• 居家照护环境

全球伴侣动物保健市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 医院药房
• 零售药房
• 网路药房

全球伴侣动物保健市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Zoetis Inc.
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Ceva Sante Animale
• Virbac
• Vetoquinol SA
• Heska Corporation
• IDEXX Laboratories, Inc.
• Dechra Pharmaceuticals PLC
• Phibro Animal Health Corporation
• Ourofino Saude Animal
• Neogen Corporation
• Ceva Animal Health LLC

结论与建议

Companion Animal Healthcare Market size was valued at USD 27.38 Billion in 2024 and is poised to grow from USD 29.68 Billion in 2025 to USD 56.59 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The trend towards remote work has significantly contributed to an increase in pet adoption, as individuals seek companionship to combat feelings of depression and anxiety stemming from social isolation. Research indicates a notable presence of companion animals in households, with a substantial portion of households owning pets. The prevalence of cancer, particularly among dogs, is anticipated to further propel market growth in companion animal healthcare, emphasizing the need for enhanced veterinary services and treatments. Alongside this, the rising trend of pet ownership has prompted companies to pursue strategic initiatives to expand their market share in animal healthcare. Such initiatives, including acquisitions, are expected to improve access to advanced veterinary facilities, thereby fostering continued growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Healthcare Market Segments Analysis

Global Companion Animal Healthcare Market is segmented by product type, animal type, end user, distribution channel and region. Based on product type, the market is segmented into pharmaceuticals (antibiotics, anti-inflammatory drugs, parasiticides, pain management, others), vaccines (live attenuated vaccines, inactivated vaccines, recombinant vaccines, others), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, others) and feed additives (nutritional feed additives, medicinal feed additives). Based on animal type, the market is segmented into dogs, cats, horses and other. Based on end user, the market is segmented into veterinary hospitals & clinics, diagnostic laboratories, research institutes and home care settings. Based on distribution channel, the market is segmented into Hospital Pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Healthcare Market

The rising trend of pet ownership worldwide serves as a significant catalyst for the Companion Animal Healthcare market. As individuals increasingly choose to welcome pets into their lives for companionship, there is a growing need for health-related services, including veterinary care, vaccinations, and wellness products. This surge in pet adoption can be attributed to various factors, such as urban living, evolving lifestyles, and heightened awareness of the advantages associated with having pets. Consequently, the demand for healthcare solutions tailored to companion animals continues to expand, reflecting the shifting dynamics of human-animal relationships and the prioritization of pets' well-being.

Restraints in the Companion Animal Healthcare Market

One significant limitation within the Companion Animal Healthcare market is the elevated cost of veterinary services. While advanced medical treatments and procedures can significantly improve animal health, their high expenses create a financial burden for many pet owners. This economic barrier can restrict access to essential healthcare, particularly for those with lower to moderate incomes, ultimately hindering the provision of comprehensive health solutions for their pets. As a result, many pet owners may struggle to afford necessary treatments, leading to underutilization of healthcare resources and a potential decline in overall animal well-being.

Market Trends of the Companion Animal Healthcare Market

The companion animal healthcare market is experiencing a notable trend towards the increasing adoption of pet insurance, driven by a combination of heightened awareness among pet owners regarding the financial benefits of such policies and the escalating costs associated with veterinary care. As pet owners seek to enhance their pets' well-being without incurring substantial financial burdens, the demand for comprehensive insurance coverage is on the rise. This shift not only reflects a growing commitment to responsible pet ownership but also signifies a broader cultural change towards prioritizing the health and wellness of companion animals, thereby shaping the future landscape of pet healthcare services.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Companion Animal Healthcare Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
  • Antibiotics
  • Anti-inflammatory Drugs
  • Parasiticides
  • Pain Management
  • Others
• Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Others
• Diagnostics
  • Immunodiagnostic Tests
  • Molecular Diagnostics
  • Diagnostic Imaging
  • Clinical Chemistry
  • Others
• Feed Additives
  • Nutritional Feed Additives
  • Medicinal Feed Additives

Global Companion Animal Healthcare Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Other

Global Companion Animal Healthcare Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutes
• Home Care Settings

Global Companion Animal Healthcare Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Companion Animal Healthcare Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, End User, Distribution Channel, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, End User, Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product Type, Animal Type, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product Type, Animal Type, End User, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Saude Animal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation